Meeting
2023 ASCO Annual Meeting
Impact of HER2 assay sensitivity on the ability to detect tumors with low to ultra-low HER2 expression: A TMA study on more than 10,000 tumors from more than 100 tumor entities.
Authors
Maximilian Lennartz
University Medical Center Hamburg-Eppendorf, Hamburg, Germany
Maximilian Lennartz , Niclas C. Blessin , Simon Kind , Florian Viehweger , David Dum , Doris Höflmeyer , Christoph Fraune , Christian Bernreuther , Patrick Lebok , Sören Weidemann , Guido Sauter , Till S Clauditz , Frank Jacobsen , Till Krech , Andreas H. Marx , Sarah Minner , Ronald Simon , Natalia Gorbokon , Stefan Steurer , Eike C Burandt
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Developmental Therapeutics—Molecularly Targeted Agents and Tumor Biology
Track
Developmental Therapeutics—Molecularly Targeted Agents and Tumor Biology
Sub Track
Tissue-Based Biomarkers
Citation
J Clin Oncol 41, 2023 (suppl 16; abstr 3137)
DOI
10.1200/JCO.2023.41.16_suppl.3137
Abstract #
3137
Poster Bd #
335
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Computational pathology–based HER2 quantification to identify novel biomarkers in gastric cancer (GC).
First Author: Ansh Kapil
Poster
2019 Gastrointestinal Cancers Symposium
Comparison of HER2 expression by immunohistochemistry and HER2 copy number by digital PCR in tumor tissue during treatment with trastuzumab in the prospective cohort of metastatic HER2-positive gastric cancer patients.
First Author: Naoki Takahashi
Poster
2014 Gastrointestinal Cancers Symposium
A novel method combining gene and protein platforms on one slide for the detection of HER2 in gastric cancer: Final results.
First Author: Dominique Werner
Poster
2013 Gastrointestinal Cancers Symposium
Significance of accurate HER2 testing as a new biomarker in advanced gastric cancer.
First Author: Tetsuya Kusumoto